This is a common in vivo finding even in healthy elderly volunteers as well as in AD patients whose brains are not expected to harbor tau pathology in that region pointing to off-target retention in “on-target” PSP and CBD regions [8]. This evidence concerns the gene MAPT and Alzheimer disease.